Conference Coverage (ISVH)

Longer and Higher-Dose IFN Treatment Advocated

Published in Hepatitis Weekly, March 4th, 1996

Prolonged treatment with interferon-alpha appears superior to less aggressive therapy in patients with chronic hepatitis D infection, according to a report from Italy.

The report was one of several suggesting a response benefit to longer-term or higher-dose interferon in patients with chronic hepatitis delivered at the VII International Symposium on Viral Hepatitis, held January 25-27, 1996 in Madrid, Spain.

Researcher E. Minola and colleagues from Bergamo, Italy's Hospital Riuniti evaluated the efficacy of long-term interferon treatment in chronic hepatitis D virus (HDV) patients.

Chronic hepatitis D is usually a severe and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1996-03-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry